Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NACDS Marketplace In Brief

This article was originally published in The Tan Sheet

Executive Summary

Matrixx prepares to launch cold products: Matrixx Initiatives prepares to launch two oral Zicam Cold Remedy products in July and August, CEO Bill Hemelt said at the National Association of Chain Drugstores Marketplace conference and trade show in San Diego June 5-8 (1"The Tan Sheet" May 17, 2010). The products are in the Cold Remedy Plus line - an oral mist and a rapid melt. The suggested retail price for the products is $11.99, he said

You may also be interested in...



Matrixx Projects Profit, But Zicam Litigation "Storm Clouds" Could Still Rain

Matrixx Initiatives believes it has emerged with a plan for returning to growth and profitability after navigating the gauntlet of an FDA warning, product recall and millions in lost revenue in fiscal 2010

Marketing In Brief

Avon: Limited-edition makeup collection inspired by floral motif from Finnish design firm Marimekko will debut in fall, Avon says. Marimekko for Avon combines beauty firm's "fun, fresh color formulas" with Marimkko's "signature brilliant hues and simple, yet sophisticated design" in items for the eyes and face. Palettes and packaging will sport design firm's iconic Unikko poppy pattern. Collection consists of All Over Face Palette ($10) and Eyeshadow Palette ($8) in two blendable shade combinations - Poppy Bloom and Poppy Bouquet - and will be available from Avon representatives in October...

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104229

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel